INDV Indivior Plc

TIDMINDV

RNS Number : 0573R

Indivior PLC

02 November 2021

Indivior to Participate in Upcoming Healthcare Investor Conferences

Richmond, VA, November 2, 2021 - Indivior PLC (LON: INDV) will participate in the upcoming healthcare investor conferences:

   --    STIFEL 2021 Virtual Healthcare Conference 
   Day :                 Monday, November 15(th) : 
   Time :               8:40 AM US Eastern (13:40 London time) 
   Speaker :         Mark Crossley, CEO 
   Link :                Click here 
   --    Jefferies 2021 London Healthcare Conference 
   Day:                 Tuesday, November 16(th) 
   Time:                8:00 AM London Time (3:00 AM US Eastern) 
   Speaker:          Mark Crossley, CEO 
   Link:                 Click here 

About Indivior

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat addiction and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of opioid dependence treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and cooccurring disorders of addiction, including alcohol use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 800 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior .

Investor Contact:

Jason Thompson, Investor Relations

   Mobile:           +1804-402-7123 
   E-mail:             jason.thompson@indivior.com 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCEANFAEDFFFEA

(END) Dow Jones Newswires

November 02, 2021 05:33 ET (09:33 GMT)

Indivior (LSE:INDV)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Indivior (LSE:INDV)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024